Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2)
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.